Clinical Trials Directory

Trials / Completed

CompletedNCT02711917

Rocuronium Consumption in Etomidate-based and Propofol-based General Anesthesia Under Sevoflurane

Consumption of Rocuronium Under Etomidate-based Versus Propofol-based Maintenance of General Anesthesia Under Different Concentration of Sevoflurane- BIS Guided Clinical Trial in a Closed Loop Infusion System

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
175 (actual)
Sponsor
Tianjin Medical University General Hospital · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Accepted

Summary

Different concentration of sevoflurane was given to maintain anesthesia. The dose of propofol to maintain BIS between 40-60 and the consumption of rocuronium was recorded and evaluated.

Detailed description

2 age group of patients was selected, 40-60 years and above 60 years. Maintenance of anesthesia was carried out using different concentration of Sevoflurane, ie MAC 0.5, 0.75 and 1.0. Bis value was kept between 40-60 and the dose of propofol required was recorded. Rocuronium infusion given in a close loop infusion system for different group was tabulated. The results was then analysed.

Conditions

Interventions

TypeNameDescription
DRUGMAC 0.50.5 MAC Sevoflurane
DRUGMAC 0.750.75 MAC Sevoflurane
DRUGMAC 1.01.0 MAC Sevoflurane
DRUGPropofolPropofol consumption
DRUGEtomidateEtomidate consumption
DRUGRocuroniumConsumption of Rocuronium

Timeline

Start date
2015-07-01
Primary completion
2015-12-01
Completion
2016-01-01
First posted
2016-03-17
Last updated
2016-03-17

Source: ClinicalTrials.gov record NCT02711917. Inclusion in this directory is not an endorsement.